Simon Bjerregaard Jensen

Person

Frederiksberg, DK

People

Patents Grantslast 30 patents

Information Patent Grant
Mold, and apparatus for forming glass product, and method of proces...
- Patent number 11,401,190
- Issue date Aug 2, 2022
- AAC OPTICS SOLUTIONS PTE. LTD.
- Michal Sobol
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Grant
Mold and apparatus for forming glass product, and method of process...
- Patent number 11,401,191
- Issue date Aug 2, 2022
- AAC OPTICS SOLUTIONS PTE. LTD.
- Tsz Lok Keith Tang
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Grant
Tablet formulation comprising a GLP-1 peptide and a delivery agent
- Patent number 11,033,499
- Issue date Jun 15, 2021
- Novo Nordisk A/S
- Simon Bjerregaard Jensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tablet formulation comprising semaglutide and a delivery agent
- Patent number 9,993,430
- Issue date Jun 12, 2018
- Novo Nordisk A/S
- Simon Bjerregaard Jensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for drying a protein composition, a dried protein compositio...
- Patent number 9,387,176
- Issue date Jul 12, 2016
- Novo Nordisk A/S
- Svend Havelund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable formulation of modified GLP-1
- Patent number 8,846,618
- Issue date Sep 30, 2014
- Novo Nordisk A/S
- James M. Flink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MOLD AND APPARATUS FOR FORMING GLASS PRODUCT, AND METHOD OF PROCESS...
- Publication number 20210214263
- Publication date Jul 15, 2021
- AAC Optics Solutions Pte. Ltd.
- Tsz Lok Keith Tang
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Application
ADSORBING APPARATUS FOR GLASS WAFER
- Publication number 20210214272
- Publication date Jul 15, 2021
- AAC Optics Solutions Pte. Ltd.
- Jacob Kibsgaard Kjær
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Application
GLASS PRODUCT FORMING MOLD AND METHOD OF PROCESSING GLASS PRODUCT
- Publication number 20210214259
- Publication date Jul 15, 2021
- AAC Optics Solutions Pte. Ltd.
- Simon Bo Jensen
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Application
GLASS PRODUCT FORMING MOLD, GLASS PRODUCT FORMING DEVICE, AND GLASS...
- Publication number 20210214260
- Publication date Jul 15, 2021
- AAC Optics Solutions Pte. Ltd.
- Peter Krohne Nielsen
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Application
GLASS PRODUCT FORMING MOLD, GLASS PRODUCT FORMING DEVICE, AND METHO...
- Publication number 20210214261
- Publication date Jul 15, 2021
- AAC Optics Solutions Pte. Ltd.
- Thomas Aabo
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Application
MOLD, AND APPARATUS FOR FORMING GLASS PRODUCT, AND METHOD OF PROCES...
- Publication number 20210214262
- Publication date Jul 15, 2021
- AAC Optics Solutions Pte. Ltd.
- Michal Sobol
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Application
SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2...
- Publication number 20180360918
- Publication date Dec 20, 2018
- Novo Nordisk A/S
- Per Sauerberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TABLET FORMULATION COMPRISING SEMAGLUTIDE AND A DELIVERY AGENT
- Publication number 20180235888
- Publication date Aug 23, 2018
- Novo Nordisk A/S
- Simon Bjerregaard Jensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT
- Publication number 20150150811
- Publication date Jun 4, 2015
- Novo Nordisk A/S
- Simon Bjerregaard Jensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE FORMULATION OF MODIFIED GLP-1
- Publication number 20100234299
- Publication date Sep 16, 2010
- Novo Nordisk A/S
- James M. Flink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stable Formulation of Modified GLP-1
- Publication number 20090111752
- Publication date Apr 30, 2009
- Novo Nordisk A/S
- James M. Flink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stable formulation of modified GLP-1
- Publication number 20080167226
- Publication date Jul 10, 2008
- Novo Nordisk A/S
- James M. Flink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Long-acting molecules in sustained release formulations
- Publication number 20060257479
- Publication date Nov 16, 2006
- Novo Nordisk A/S
- Simon Bjerregaard Jensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic use of factor XI
- Publication number 20050181978
- Publication date Aug 18, 2005
- Rasmus Rojkjaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stable formulation of modified GLP-1
- Publication number 20030119734
- Publication date Jun 26, 2003
- James M. Flink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Simon Bjerregaard Jensen

Person

Patents Grantslast 30 patents

Mold, and apparatus for forming glass product, and method of proces...

Mold and apparatus for forming glass product, and method of process...

Tablet formulation comprising a GLP-1 peptide and a delivery agent

Tablet formulation comprising semaglutide and a delivery agent

Method for drying a protein composition, a dried protein compositio...

Stable formulation of modified GLP-1

Patents Applicationslast 30 patents

MOLD AND APPARATUS FOR FORMING GLASS PRODUCT, AND METHOD OF PROCESS...

ADSORBING APPARATUS FOR GLASS WAFER

GLASS PRODUCT FORMING MOLD AND METHOD OF PROCESSING GLASS PRODUCT

GLASS PRODUCT FORMING MOLD, GLASS PRODUCT FORMING DEVICE, AND GLASS...

GLASS PRODUCT FORMING MOLD, GLASS PRODUCT FORMING DEVICE, AND METHO...

MOLD, AND APPARATUS FOR FORMING GLASS PRODUCT, AND METHOD OF PROCES...

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2...

TABLET FORMULATION COMPRISING SEMAGLUTIDE AND A DELIVERY AGENT

TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT

STABLE FORMULATION OF MODIFIED GLP-1

Stable Formulation of Modified GLP-1

Stable formulation of modified GLP-1

Long-acting molecules in sustained release formulations

Therapeutic use of factor XI

Stable formulation of modified GLP-1